294 related items for PubMed ID: 19179878
1. Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms.
Pfefferkorn M, Burke G, Griffiths A, Markowitz J, Rosh J, Mack D, Otley A, Kugathasan S, Evans J, Bousvaros A, Moyer MS, Wyllie R, Oliva-Hemker M, Carvalho R, Crandall W, Keljo D, Walters TD, LeLeiko N, Hyams J.
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):168-74. PubMed ID: 19179878
[Abstract] [Full Text] [Related]
2. Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease.
Markowitz J, Hyams J, Mack D, Leleiko N, Evans J, Kugathasan S, Pfefferkorn M, Mezoff A, Rosh J, Tolia V, Otley A, Griffiths A, Moyer MS, Oliva-Hemker M, Wyllie R, Rothbaum R, Bousvaros A, Del Rosario JF, Hale S, Lerer T, Pediatric IBD Collaborative Research Group.
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1124-9. PubMed ID: 16861053
[Abstract] [Full Text] [Related]
3. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.
Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Chen DM, Pritchard ML, Sandborn WJ.
Clin Gastroenterol Hepatol; 2006 May; 4(5):621-30. PubMed ID: 16678077
[Abstract] [Full Text] [Related]
4. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Liu G, Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano R, REACH Study Group.
Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
[Abstract] [Full Text] [Related]
5. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
Navarro FA, Hanauer SB, Kirschner BS.
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):312-8. PubMed ID: 17873743
[Abstract] [Full Text] [Related]
6. Outcome following infliximab therapy in children with ulcerative colitis.
Hyams JS, Lerer T, Griffiths A, Pfefferkorn M, Stephens M, Evans J, Otley A, Carvalho R, Mack D, Bousvaros A, Rosh J, Grossman A, Tomer G, Kay M, Crandall W, Oliva-Hemker M, Keljo D, LeLeiko N, Markowitz J, Pediatric Inflammatory Bowel Disease Collaborative Research Group.
Am J Gastroenterol; 2010 Jun; 105(6):1430-6. PubMed ID: 20104217
[Abstract] [Full Text] [Related]
7. The natural history of corticosteroid therapy for ulcerative colitis in children.
Hyams J, Markowitz J, Lerer T, Griffiths A, Mack D, Bousvaros A, Otley A, Evans J, Pfefferkorn M, Rosh J, Rothbaum R, Kugathasan S, Mezoff A, Wyllie R, Tolia V, delRosario JF, Moyer MS, Oliva-Hemker M, Leleiko N, Pediatric Inflammatory Bowel Disease Collaborative Research Group.
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1118-23. PubMed ID: 16820327
[Abstract] [Full Text] [Related]
8. Capsule endoscopy in the evaluation of patients with unexplained growth failure.
Moy L, Levine J.
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):647-50. PubMed ID: 19367183
[Abstract] [Full Text] [Related]
9. [Long-term outcome of infliximab therapy in pediatric Crohn disease].
Wanty C, Stephenne X, Sokal E, Smets F.
Arch Pediatr; 2011 Aug; 18(8):863-9. PubMed ID: 21723101
[Abstract] [Full Text] [Related]
10. Clinical features affecting final adult height in patients with pediatric-onset Crohn's disease.
Sawczenko A, Ballinger AB, Savage MO, Sanderson IR.
Pediatrics; 2006 Jul; 118(1):124-9. PubMed ID: 16818557
[Abstract] [Full Text] [Related]
11. Long term nutritional rehabilitation by gastrostomy in Israeli patients with cystic fibrosis: clinical outcome in advanced pulmonary disease.
Efrati O, Mei-Zahav M, Rivlin J, Kerem E, Blau H, Barak A, Bujanover Y, Augarten A, Cochavi B, Yahav Y, Modan-Moses D.
J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):222-8. PubMed ID: 16456419
[Abstract] [Full Text] [Related]
12. Growth and early onset inflammatory bowel disease.
Ceballos C.
Gastroenterol Nurs; 2008 Feb; 31(2):101-4; quiz 104-6. PubMed ID: 18391796
[Abstract] [Full Text] [Related]
13. Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study.
Thayu M, Leonard MB, Hyams JS, Crandall WV, Kugathasan S, Otley AR, Olson A, Johanns J, Marano CW, Heuschkel RB, Veereman-Wauters G, Griffiths AM, Baldassano RN, Reach Study Group.
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1378-84. PubMed ID: 19081527
[Abstract] [Full Text] [Related]
14. A 5-year prospective observational study of the outcomes of international treatment guidelines for Crohn's disease.
Cullen G, Keegan D, Mulcahy HE, O'Donoghue DP.
Clin Gastroenterol Hepatol; 2009 Mar; 7(3):323-8; quiz 252. PubMed ID: 19174193
[Abstract] [Full Text] [Related]
15. Continuous elemental enteral alimentation in children with Crohn's disease and growth failure.
Morin CL, Roulet M, Roy CC, Weber A.
Gastroenterology; 1980 Dec; 79(6):1205-10. PubMed ID: 6777234
[Abstract] [Full Text] [Related]
16. Attained adult height in juvenile rheumatoid arthritis with or without corticosteroid treatment.
Wang SJ, Yang YH, Lin YT, Yang CM, Chiang BL.
Clin Rheumatol; 2002 Sep; 21(5):363-8. PubMed ID: 12223982
[Abstract] [Full Text] [Related]
17. Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases.
Newby EA, Croft NM, Green M, Hassan K, Heuschkel RB, Jenkins H, Casson DH.
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):539-45. PubMed ID: 18493209
[Abstract] [Full Text] [Related]
18. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens.
Rasat R, Espiner EA, Abbott GD.
N Z Med J; 1995 Aug 11; 108(1005):311-4. PubMed ID: 7644165
[Abstract] [Full Text] [Related]
19. [Relationship between bone mineral content and growth disorders in children with juvenile idiopathic arthritis].
Górska A, Urban M, Konstantynowicz J, Bartnicka M, Chlabicz S, Górski S, Kaczmarski M.
Pol Merkur Lekarski; 2008 Mar 11; 24(141):227-30. PubMed ID: 18634288
[Abstract] [Full Text] [Related]
20. Growth of children on classical and medium-chain triglyceride ketogenic diets.
Neal EG, Chaffe HM, Edwards N, Lawson MS, Schwartz RH, Cross JH.
Pediatrics; 2008 Aug 11; 122(2):e334-40. PubMed ID: 18676520
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
